Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cytosorbents Cor (NQ: CTSO )

7.610 USD -0.010 (-0.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 147,569
Open 7.700
Bid (Size) 7.640 (10)
Ask (Size) 8.490 (1)
Prev. Close 7.620
Today's Range 7.580 - 7.750
52wk Range 7.130 - 11.68
Shares Outstanding 43,319,297
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CytoSorbents Completes its Mission 100,000 International Fundraising Campaign to Fight the Spread of COVID-19 for Global Humanitarian Organization, CARE
CytoSorbents to present a $100,000 check to CARE during the Opening Bell ceremony at NASDAQ today in New York City Times Square 
From PR Newswire
CytoSorbents to Report Second Quarter 2021 Operating and Financial Results
CytoSorbents Corporation (NASDAQ: CTSO) a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer... 
From PR Newswire

Performance

YTD
-9.08%
-9.08%
1 Month
+0.93%
+0.93%
3 Month
-17.28%
-17.28%
6 Month
-29.08%
-29.08%
1 Year
-20.52%
-20.52%

More News

Read More
CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery
From PR Newswire
CytoSorbents Appoints Terri Anne Powers, IRC as Vice President of Investor Relations and Corporate Communications
From PR Newswire
CytoSorbents to Present at the Jefferies Virtual Healthcare Conference
From PR Newswire
CytoSorb® Registered and Commercially Available in Singapore
From PR Newswire
CytoSorbents to Present at the UBS Global Healthcare Virtual Conference and Oppenheimer MedTech, Tools and Diagnostic Summit
From PR Newswire
NIRI Chicago Elects 2021-2022 Officers and Directors
From Business Wire News Releases
CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance the Treatment of Severe Hyperkalemia in Traumatic Injury
From PR Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tags SNGX Top Gainers MOR
From Benzinga
CytoSorbents Shares Are Trading Higher On Launch Of Trial On Ticagrelor Removal During Cardiothoracic Surgery
Tags Market News Benzinga Health Care
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.